Leuprolide Completed Phase 2 Trials for Insulin Resistance / one to five years postmenopausal Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00123110Insulin Resistance and Testosterone in Women